Australia TGA ARTG recordTissue Morcellation System - Tissue morcellation system
Australia TGA ARTG Registered Device · Videra Surgical & Diagnostics Pty Ltd · Veol Medical Technologies Pvt Ltd · Class IIa · Started March 25, 2019
Good Name: Videra Surgical & Diagnostics Pty Ltd - Tissue Morcellation System - Tissue morcellation system
- Risk Class
- Class IIa
- Product Type
- Medical device system
- ARTG Category
- General
- Start Date
- March 25, 2019
- Effective Date
- March 25, 2019
- Country
- India
- Address
- Plot A- 747 Near Pawan Bus Stop Pawane MIDC TTC Industrial Estate Koparkhairne, Navi Mumbai, Maharashtra, 400705
Tissue Morcellation System is intended to be used for gynaecologic, urologic and general surgical endoscopic use for the extraction of tissues during laparoscopic general surgery, laparoscopic urologic surgery and laparoscopic gynaecologic surgery.
Access comprehensive regulatory information for Tissue Morcellation System - Tissue morcellation system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Videra Surgical & Diagnostics Pty Ltd, manufactured by Veol Medical Technologies Pvt Ltd in India. The device registration started on March 25, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.